Tower Research Capital LLC (TRC) - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 93 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$40,000
-25.9%
7,520
-32.7%
0.00%0.0%
Q1 2021$54,000
+315.4%
11,180
+269.5%
0.00%
Q4 2020$13,000
-55.2%
3,026
-57.5%
0.00%
Q3 2020$29,000
+1350.0%
7,126
+761.7%
0.00%
Q2 2020$2,000
-85.7%
827
-82.4%
0.00%
-100.0%
Q1 2020$14,000
+180.0%
4,704
+367.1%
0.00%
Q3 2019$5,000
-66.7%
1,007
-51.9%
0.00%
-100.0%
Q1 2019$15,000
+150.0%
2,093
+176.9%
0.00%
Q4 2018$6,000
-96.3%
756
-90.7%
0.00%
-100.0%
Q3 2018$162,000
+200.0%
8,099
+261.4%
0.01%
+140.0%
Q1 2018$54,000
+74.2%
2,241
+51.1%
0.01%
+66.7%
Q3 2017$31,000
-71.6%
1,483
-76.2%
0.00%
-75.0%
Q2 2017$109,000
+505.6%
6,233
+487.5%
0.01%
+500.0%
Q4 2016$18,000
+800.0%
1,061
+961.0%
0.00%
Q2 2016$2,000
-97.3%
100
-98.1%
0.00%
-100.0%
Q1 2016$75,000
+56.2%
5,177
+82.4%
0.01%
+120.0%
Q3 2015$48,000
+269.2%
2,838
+288.8%
0.01%
+150.0%
Q1 2015$13,000
-61.8%
730
-63.2%
0.00%
-33.3%
Q4 2014$34,000
-37.0%
1,983
-33.2%
0.00%
-57.1%
Q2 2014$54,0002,9690.01%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,423,578$8,826,0006.08%
Healthcare Value Capital, LLC 200,000$1,240,0002.33%
ARMISTICE CAPITAL, LLC 2,700,000$16,740,0001.06%
DELTEC ASSET MANAGEMENT LLC 550,836$3,415,0000.75%
Broadfin Capital, LLC 441,088$2,735,0000.60%
Kerrisdale Advisers, LLC 229,347$1,422,0000.51%
Worth Venture Partners, LLC 87,908$545,0000.30%
Mosaic Family Wealth, LLC 91,314$566,0000.24%
EMERALD ADVISERS, LLC 700,176$4,341,0000.17%
EMERALD MUTUAL FUND ADVISERS TRUST 616,664$3,823,0000.15%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders